ReviewFrontiers in medicine2025

Emerging therapies targeting lipoprotein(a): the next frontier in cardiovascular risk reduction.

Ibrahim S AlhomoudPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.